GEN - Genetic Engineering & Biotech NewsOriginal article
StockWatch: New UC Data Sparks Smoother Sailing for Abivax
Data ReadoutpositiveobefazimodPositive
AI Analysis
Summary
Abivax shares surged 63% in Europe and 50% in the US following new positive ulcerative colitis data for obefazimod, reassuring investors after recent safety concerns.
Clinical Trial Data
Phase
Phase 3
Outcome Details
New UC data reassured investors following earlier safety signals
Importance:6/10
Sentiment:
0.75
ulcerative colitislate-stage developmentsafety signalsstock movementobefazimod
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on July 5, 2026 9:15 PM